COMPASS Pathways plc(CMPS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CMPS Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for COMPASS Pathways plc (CMPS), a Healthcare sector company. CMPS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of CMPS by reported 13-F value include Deep Track Capital, RTW INVESTMENTS, BIT Capital GmbH, based on the most recent SEC filings. CMPS trades on the Nasdaq exchange and files with the SEC under CIK 1816590. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CMPS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COMPASS Pathways plc directly from SEC EDGAR.
Net Income
Q2 2026
$-253.8M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-85.6% YoYOperating Income
-0.5% YoYEPS (Diluted)
-33.9% YoYTotal Assets
-1.6% YoYTotal Debt
+61.9% YoYOp. Cash Flow
-31.9% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-287.9M -85.6% | $-155.1M -30.9% | $-118.5M -29.5% | $-91.5M -27.5% | $-71.7M -18.9% | $-60.3M |
| Operating Income | $-179.0M -0.5% | $-178.2M -30.2% | $-136.9M -24.0% | $-110.4M -32.7% | $-83.2M -61.9% | $-51.4M |
| EPS (Diluted) | $-3.08 -33.9% | $-2.30 +0.9% | $-2.32 -7.4% | $-2.16 -20.7% | $-1.79 +49.6% | $-3.55 |
| Total Assets | $210.3M -1.6% | $213.7M -22.6% | $276.0M +39.9% | $197.3M -34.4% | $300.9M +47.9% | $203.5M |
| Total Debt | $66.7M +61.9% | $41.2M +43.2% | $28.8M | $0.00 | — | — |
| Operating Cash Flow | $-157.2M -31.9% | $-119.2M -22.4% | $-97.4M +7.7% | $-105.5M -55.7% | $-67.7M -63.7% | $-41.4M |
| Free Cash Flow | — | $-119.2M -22.3% | $-97.4M +8.1% | $-106.0M -55.8% | $-68.1M -64.0% | $-41.5M |
Get alerted when CMPS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for COMPASS Pathways plc including:
Top Institutional Holders of CMPS
Deep Track Capital, LP
$172.1M12,161,496 shRTW INVESTMENTS, LP
$151.4M10,700,974 shBIT Capital GmbH
$89.8M6,348,797 shTANG CAPITAL MANAGEMENT LLC
$70.8M5,000,000 shTWO SIGMA INVESTMENTS, LP
$63.3M4,470,485 shMARSHALL WACE, LLP
$61.3M4,328,682 shARK Investment Management LLC
$48.8M3,451,965 shPoint72 Asset Management, L.P.
$37.1M2,620,878 shLogos Global Management LP
$31.8M2,250,000 shEagle Health Investments LP
$29.2M2,060,427 sh
| Fund | Value | Shares |
|---|---|---|
| Deep Track Capital, LP | $172.1M | 12,161,496 |
| RTW INVESTMENTS, LP | $151.4M | 10,700,974 |
| BIT Capital GmbH | $89.8M | 6,348,797 |
| TANG CAPITAL MANAGEMENT LLC | $70.8M | 5,000,000 |
| TWO SIGMA INVESTMENTS, LP | $63.3M | 4,470,485 |
| MARSHALL WACE, LLP | $61.3M | 4,328,682 |
| ARK Investment Management LLC | $48.8M | 3,451,965 |
| Point72 Asset Management, L.P. | $37.1M | 2,620,878 |
| Logos Global Management LP | $31.8M | 2,250,000 |
| Eagle Health Investments LP | $29.2M | 2,060,427 |
More Healthcare Companies
View all Healthcare →Put CMPS on your watchlist
Track score changes the day COMPASS Pathways plc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CMPS a good stock to buy?
13F Pro's AI-powered analysis of COMPASS Pathways plc (CMPS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CMPS are available on the CMPS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CMPS is classified as a small company.
Which hedge funds own CMPS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CMPS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of COMPASS Pathways plc's investment landscape.